Arizona State Retirement System’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-28,723
| Closed | -$87.3K | – | 2166 |
|
|
2024
Q4 | $87.3K | Buy |
28,723
+151
| +0.5% | +$459 | ﹤0.01% | 2103 |
|
|
2024
Q3 | $148K | Buy |
28,572
+856
| +3% | +$4.44K | ﹤0.01% | 2040 |
|
|
2024
Q2 | $71.2K | Buy |
27,716
+5,996
| +28% | +$15.4K | ﹤0.01% | 2090 |
|
|
2024
Q1 | $107K | Sell |
21,720
-1,638
| -7% | -$8.06K | ﹤0.01% | 2072 |
|
|
2023
Q4 | $205K | Sell |
23,358
-571
| -2% | -$5.02K | ﹤0.01% | 1943 |
|
|
2023
Q3 | $274K | Buy |
23,929
+377
| +2% | +$4.32K | ﹤0.01% | 1723 |
|
|
2023
Q2 | $596K | Sell |
23,552
-287
| -1% | -$7.26K | ﹤0.01% | 1318 |
|
|
2023
Q1 | $768K | Buy |
23,839
+953
| +4% | +$30.7K | 0.01% | 1151 |
|
|
2022
Q4 | $422K | Buy |
22,886
+4,100
| +22% | +$75.7K | ﹤0.01% | 1471 |
|
|
2022
Q3 | $507K | Buy |
18,786
+302
| +2% | +$8.15K | 0.01% | 1317 |
|
|
2022
Q2 | $255K | Buy |
18,484
+47
| +0.3% | +$648 | ﹤0.01% | 1774 |
|
|
2022
Q1 | $360K | Buy |
18,437
+71
| +0.4% | +$1.39K | ﹤0.01% | 1682 |
|
|
2021
Q4 | $300K | Sell |
18,366
-144
| -0.8% | -$2.35K | ﹤0.01% | 1835 |
|
|
2021
Q3 | $516K | Buy |
18,510
+78
| +0.4% | +$2.17K | ﹤0.01% | 1532 |
|
|
2021
Q2 | $546K | Buy |
18,432
+997
| +6% | +$29.5K | ﹤0.01% | 1525 |
|
|
2021
Q1 | $487K | Buy |
17,435
+228
| +1% | +$6.37K | ﹤0.01% | 1553 |
|
|
2020
Q4 | $488K | Buy |
17,207
+1,713
| +11% | +$48.6K | ﹤0.01% | 1463 |
|
|
2020
Q3 | $390K | Buy |
15,494
+3,930
| +34% | +$98.9K | ﹤0.01% | 1454 |
|
|
2020
Q2 | $282K | Buy |
11,564
+660
| +6% | +$16.1K | ﹤0.01% | 1468 |
|
|
2020
Q1 | $161K | Buy |
+10,904
| New | +$161K | ﹤0.01% | 1560 |
|